Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein

Journal of Cystic Fibrosis

Volumn 2, Issue 4, 2003, Pages 195-198

  Grey, Vijaylaxmi ^a   Mohammed, Shawn R ^b   Smountas, Argyrios A ^b   Bahlool, Rasha ^b   Lands, Larry C ^b  

^a Hamilton Health Sciences   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Cystic fibrosis; Glutathione; Whey

Indexed keywords

ANTIOXIDANT; CASEIN; GLUTATHIONE; IMMUNOCAL; MILK PROTEIN; OXIDIZING AGENT; PLACEBO;

ADULT; AGE; ARTICLE; BODY FAT; BODY HEIGHT; BODY WEIGHT; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; FEMALE; HUMAN; LUNG DISEASE; MALE; NUTRITIONAL STATUS; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; CYSTIC FIBROSIS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GLUTATHIONE; HUMANS; MALE; MILK PROTEINS; PROBABILITY; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0242488033     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-1993(03)00097-3     Document Type: Article

References (22)

1. Blackwell T.S. Stecenko A.A. Christman J.W. Dysregulated NF-kappaB activation in cystic fibrosis: evidence for a primary inflammatory disorder Am J Physiol Lung Cell Mol Physiol 281 1 2001 L69-L70
2. DiMango E. Ratner A.J. Bryan R. Tabibi S. Prince A. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells J Clin Invest 101 11 1998 2598-2605
3. Cantin A.M. Paquette B. Richter M. Larivee P. Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation' Am J Respir Crit Care Med 162 4 Pt 2000 1539-1546
4. Lands L.C. Grey V.L. Smountas A.A. Kramer V.G. McKenna D. Lymphocyte glutathione levels in children with cystic fibrosis Chest 116 1 1999 201-205
5. Lands L.C. Grey V.L. Smountas A.A. The effect of supplementation with a cysteine donor on muscular performance J Appl Physiol 87 4 1999 1381-1385
6. Jain A. Madsen D.C. Auld P.A. Frayer W.W. Schwartz M.K. Meister A. et al. l-2-oxothiazolidine-4-carboxylate, a cysteine precursor, stimulates growth and normalizes tissue glutathione concentrations in rats fed a sulfur amino acid-deficient diet J Nutr 125 4 1995 851-856
7. Martensson J. Jain A. Frayer W. Meister A. Glutathione metabolism in the lung: inhibition of its synthesis leads to lamellar body and mitochondrial defects Proc Natl Acad Sci USA 86 14 1989 5296-5300
8. Ramsey B.W. Farrell P.M. Pencharz P. Nutritional assessment and management in cystic fibrosis: a consensus report Am J Clin Nutr 55 1 1992 108-116
9. Lands L.C. Gordon C. Bar-Or O. Blimkie C.J. Hanning R.M. Jones N.L. et al. Comparison of three techniques for body composition analysis in cystic fibrosis J Appl Physiol 75 1 1993 162-166
10. Polgar G. Promadhat V. Pulmonary Function Testing in Children 1971 WB Saunders Co Philidelphia
11. Morris J.F. Spirometry in the evaluation of pulmonary function West J Med 125 2 1976 110-118
12. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues Anal Biochem 27 3 1969 502-522
13. Grey V.L. Kramer V.G. Lands L.C. The determination of oxidised and reduced glutathione in circulating lymphocytes using the Cobas Mira S (Abstract) Clin Biochem 31 1998 301
14. Meister A. Glutathione biosynthesis and its inhibition Methods Enzymol 252 1995 26-30
15. Linsdell P. Hanrahan J.W. Glutathione permeability of CFTR Am J Physiol 275 1:Pt 1 1998 C323-C326
16. Gao L. Kim K.J. Yankaskas J.R. Forman H.J. Abnormal glutathione transport in cystic fibrosis airway epithelia Am J Physiol 277 1 Pt 1 1999 L113-L118
17. Hull J. Vervaart P. Grimwood K. Phelan P. Pulmonary oxidative stress response in young children with cystic fibrosis Thorax 52 6 1997 557-560
18. Velsor L.W. van Heeckeren A. Day B.J. Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice Am J Physiol Lung Cell Mol Physiol 281 1 2001 L31-L38
19. Khan T.Z. Wagener J.S. Bost T. Martinez J. Accurso F.J. Riches D.W. Early pulmonary inflammation in infants with cystic fibrosis Am J Respir Crit Care Med 151 4 1995 1075-1082
20. Konstan M.W. Byard P.J. Hoppel C.L. Davis P.B. Effect of high-dose ibuprofen in patients with cystic fibrosis N Engl J Med 332 13 1995 848-854
21. Buhl R. Vogelmeier C. Critenden M. Hubbard R.C. Hoyt Jr. R.F. Wilson E.M. et al. Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol Proc Natl Acad Sci USA 87 11 1990 4063-4067
22. Wendel A. Cikryt P. The level and half-life of glutathione in human plasma FEBS Lett 120 2 1980 209-211